Monday, November 09, 2009 3:25:04 PM
United States Patent Application 20090214596
Kind Code A1
Seino; Ken-ichiro ; et al. August 27, 2009
--------------------------------------------------------------------------------
Nasal Vaccine
Abstract
The present invention provides a nasal vaccine capable of intranasally inducing an effective immunity reaction. Specifically, the invention provides a nasal vaccine containing a compound having an NKT cell-activating action, particularly a compound represented by the formula (I): ##STR00001## wherein each symbol is as defined in the specification, or a compound represented by the formula (II): ##STR00002## wherein each symbol is as defined in the specification, and an immunogen in an amount effective for stimulating an immune response.
Full application found here:
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PG01&s1=hasegawa.IN.&s2=riken.AS.&OS=IN/hasegawa+AND+AN/riken&RS=IN/hasegawa+AND+AN/riken
Anyone know the formula for Ampligen?
Interested in comparing.
Application filed March 30, 2006
Assignee: RIKEN
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM